A Phase 3 Randomized Trial of Concurrent Cisplatin and Radiotherapy With Or Without ONCOVEXGM-CSF In Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck.

Trial Profile

A Phase 3 Randomized Trial of Concurrent Cisplatin and Radiotherapy With Or Without ONCOVEXGM-CSF In Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Talimogene laherparepvec (Primary) ; Cisplatin
  • Indications Head and neck cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors BioVex
  • Most Recent Events

    • 29 Jul 2011 Status changed from recruiting to discontinued.
    • 10 Dec 2010 Status changed from not yet recruiting to recruiting.
    • 02 Aug 2010 Status changed from planning to not yet recruiting, as reported in a BioVex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top